These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5317642)

  • 1. delta-aminolevulinic acid synthetase from the particulate fraction of liver of porphyric rats.
    Kaplan BH
    Biochim Biophys Acta; 1971 May; 235(2):381-8. PubMed ID: 5317642
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of DL-propranolol on delta-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria.
    Blum I; Schoenfeld N; Atsmon A
    Biochim Biophys Acta; 1973 Sep; 320(2):242-8. PubMed ID: 4750745
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on hepatic -aminolevulinic acid synthetase.
    Patton GM; Beattie DS
    J Biol Chem; 1973 Jun; 248(12):4467-74. PubMed ID: 4711614
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on mammalian hepatic delta-aminolevulinic acid synthetase.
    Woods JS
    Environ Health Perspect; 1973 Sep; 5():221-5. PubMed ID: 4752905
    [No Abstract]   [Full Text] [Related]  

  • 5. Cimetidine suppresses chemically induced experimental hepatic porphyria.
    Marcus DL; Nadel H; Lew G; Freedman ML
    Am J Med Sci; 1990 Oct; 300(4):214-7. PubMed ID: 2248274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial metabolism in porphyric rat liver.
    Miyahara M; Hirata K; Tada H; Seno S
    Biochim Biophys Acta; 1973 Oct; 325(1):47-53. PubMed ID: 4358812
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Studies in rats and mice.
    De Matteis F; Abbritti G; Gibbs AH
    Biochem J; 1973 Jul; 134(3):717-27. PubMed ID: 4749272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic porphyria induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse.
    Goldstein JA; Hickman P; Bergman H; Vos JG
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):919-28. PubMed ID: 4760898
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of haem arginate and haematin upon the allylisopropylacetamide induced experimental porphyria in rats.
    Tokola O; Lindén IB; Tenhunen R
    Pharmacol Toxicol; 1987 Jul; 61(1):75-8. PubMed ID: 3628186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enzymatic studies on porphyria. II. Liver delta-aminolevulinic acid dehydrase activity in griseofulvin induced protoporphyria mice].
    Murayama F
    Nihon Hifuka Gakkai Zasshi; 1987 Jul; 97(8):899-903. PubMed ID: 3430787
    [No Abstract]   [Full Text] [Related]  

  • 11. The control of delta-aminolevulinic acid synthetase in rat liver mitochondria. Effect of pyrazole on the apparent 'induction'.
    Beattie DS; Patton GM; Rubin E
    Enzyme; 1973; 16(1):252-7. PubMed ID: 4791046
    [No Abstract]   [Full Text] [Related]  

  • 12. Aging-related decreases in hepatic mitochondrial and cytosolic delta-aminolevulinic acid synthase during experimental porphyria.
    Scotto AW; Rinehart RW; Beattie DS
    Arch Biochem Biophys; 1983 Apr; 222(1):150-7. PubMed ID: 6838217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of the conversion of cytosol delta-aminolevulinic acid synthase to the mitochondrial enzyme in the liver of the allylisopropylacetamide-treated rat.
    Oashi A; Kikuchi G
    Arch Biochem Biophys; 1977 Jan; 178(2):607-16. PubMed ID: 836047
    [No Abstract]   [Full Text] [Related]  

  • 14. Ferrochelatase and -aminolaevulate synthetase in brain, heart, kidney and liver of normal and porphyric rats. The induction of -aminolaevulate synthetase in kidney cytosol and mitochondria by allylisopropylacetamide.
    Barnes R; Jones MS; Jones OT; Porra RJ
    Biochem J; 1971 Sep; 124(3):633-7. PubMed ID: 5135247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lead on hepatic delta-aminolaevulinic acid synthetase activity in the rat: a model for drug sensitivity in intermittent acute porphyria.
    Maxwell JD; Meyer UA
    Eur J Clin Invest; 1976 Sep; 6(5):373-9. PubMed ID: 976299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies in laboratory animals to assess the safety of anti-inflammatory agents in acute porphyria.
    McColl KE; Thompson GG; Moore MR
    Ann Rheum Dis; 1987 Jul; 46(7):540-2. PubMed ID: 3662642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allylisopropylacetamide-induced propyria-protective effect of 3,5-dimethylisooxazole.
    Pinelli A; Favalli L
    Biochem Pharmacol; 1973 Apr; 22(7):797-801. PubMed ID: 4692646
    [No Abstract]   [Full Text] [Related]  

  • 18. Enzymes in the hepatic porphyrias.
    Lancet; 1972 Jul; 2(7768):121. PubMed ID: 4113898
    [No Abstract]   [Full Text] [Related]  

  • 19. [Control of the amount of delta-aminolevulinate synthase in liver mitochondria (author's transl)].
    Hayashi N
    Seikagaku; 1979 Jun; 51(6):420-36. PubMed ID: 226633
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of actinomycin D on the activity of delta-aminolaevulinic acid synthetase and dehydratase in the liver of mice and rats treated by griseofulvin.
    Erban J; Janousek V
    Physiol Bohemoslov; 1977; (2):173-8. PubMed ID: 140391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.